SCHEMBL2705972

SCHEMBL2705972

CC(C)(C)OC(=O)N[C@](I)(C=O)Cc1ccc(Br)cc1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.45
RECQL P46063 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
CTSS P25774 1/20 0.42
CTSK P43235 1/20 0.42
AAK1 Q2M2I8 6/20 0.39
FPR3 P25089 5/20 0.39
FPR2 P25090 5/20 0.39
CACNA1B Q00975 1/20 0.38
LMNA P02545 1/20 0.37
PTPRB P23467 1/20 0.37
GAA P10253 1/20 0.36
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35
AKT1 P31749 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL255674 0.80 NPC1 (0.48) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL4380188 0.78 CTSS (0.46) SMN1; SMN2CTSSCTSKLMNAALDH1A1
SCHEMBL2436818 0.77 CTSS (0.50) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL20338607 0.77 CTSS (0.50) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL3797749 0.76 NPC1 (0.49) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL5258641 0.76 NPC1 (0.49) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL3670192 0.76 NPC1 (0.49) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL1141998 0.72 NPC1 (0.51) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL28603553 0.71 SMN1; SMN2 (0.39) NPC1RECQLRAB9ASMN1; SMN2CTSS
SCHEMBL81094 0.71 FPR3 (0.58) NPC1RECQLRAB9ASMN1; SMN2CTSS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2435402-A2 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS Novartis AG (CH) 2012-04-04 EP disclosed
WO-2010136474-A2 SUBSTITUTED AMINOBUTYRIC DERIVATIVES AS NEPRILYSIN INHIBITORS NOVARTIS AG (CH) 2010-12-02 WO disclosed